5-hydroxytryptophan and Creatine for Treatment Resistant Depression Associated With Hypoxia in Females
NCT02356107
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Major Depressive Disorder
Interventions
DRUG:
5-hydroxytryptophan and Creatine monohydrate
Sponsor
Perry Renshaw